Hetero Gets Dgci Approval For Generic Version Of Tocilizumab For Treatment Of Covid-19
Hyderabad-based drug maker Hetero today said that the drug regulator has issued Emergency Use Authorisation (EUA) to the generic version of tocilizumab, a key drug being used in treatment of Covid patients in India.
"The Drug Controller General of India (DCGI) has issued for restricted use, Emergency Use Authorisation (EUA) for the generic version of Tocilizumab," it said in a statement.
India has faced a huge shortage of tocilizumab, used to treat critica... Read More
Zydus Healthcare Launches Generic Anti-diabetic Dapagliflozin Tablets In India
The once-daily tablets are indicated as an adjunct to diet and exercise, and aim to improve glycemic control in adults with Type 2 diabetes mellitus, Zydus Healthcare said.
New Delhi: Drug firm Zydus Healthcare on Sunday said it has launched generic anti-diabetic Read More
All Licensees Allowed To Deliver Medicines At Home Since March
This was done through a notification by the Health Ministry on March 26. It implies that all Indian licensees are permitted to deliver at home and e-pharma is essentially nomenclature.
New Delhi: Amid the controversy over online delivery of medicines, it has emerged that the Union Health Ministry had given explicit approval for doorstep delivery of drugs through email since March.
Zydus Cadila Gets Dcgi Nod For World's First Drug To Treat Liver Disease
Pharmaceutical major Zydus Cadila on Thurday said it has received Drug Controller General of India (DCGI) approval for its new drug application for Saroglitazar to treat a particular condition of liver, commonly known as NASH in India.
New Delhi, Mar 5 : Pharmaceutical major Zydus Cadila on Thurday said it has received Drug Controller General of India (DCGI) approval for its new drug... Read More
Med Devices To Be Regulated As Drugs
At present, over 30 devices including syringes, cardiac stents and orthopaedic implants are classified as drugs (under Medical Device Rules), leaving a whole host of med technology companies “largely unregulated”.
Mumbai: All medical devices sold in the country will now be regulated as ‘Read More
Cipla Acquires 4 Nutrition Brands From Wanbury
The company has acquired 4 brands namely CPink, CDense, Productiv and Folinine to further strengthen its presence in women's health portfolio.
New Delhi: Homegrown pharma firm Cipla on Saturday announced the acquisition of nutrition products portfolio from Wanbury Ltd. The company has acquired 4 brands namely Read More
Drug Marketers To Be Held Responsible For Quality
Pharmaceutical companies that market medicines made by third parties in the country will now be held responsible for drug product quality with the health and family welfare ministry on Thursday issuing a notification to this effect.
ew Delhi: Pharmaceutical companies that market medicines made by third parties in the country will now be held responsible for drug product quality with ... Read More
Dr. Reddy’s Laboratories To Acquire Select Business Divisions Of Wockhardt In India
The business comprises of a portfolio of 62 brands in multiple therapy areas such as Respiratory, Neurology, VMS, Dermatology, Gastroenterology, Pain and Vaccines, which would transfer to Dr. Reddy’s along with related sales and marketing teams
Hyderabad, India February 12, 2020— Dr. Reddy’s Laboratories Ltd. (“Dr. Reddy’s”) today announced that it has entered into a definitive agreement with Read More
Price Of Diabetes Drug To Halve Soon As Cheap Versions Of Top Drug To Hit Market
The domestic pharmaceutical market is abuzz with news of over 15-20 companies launching generic versions of the widely-prescribed anti-diabetic drug Vildagliptin, with its price expected to crash by half.
MUMBAI: There is some good news for the over 72 million diabetics in India, with a cheaper version of a blockbuster drug hitting the market on December 10. The domestic pharm... Read More
Diagnostic Cos Fall On Reliance Life’s Proposed Entry
Reliance Life Sciences, the biotech subsidiary of Reliance Group, plans to start pathology labs across India through partnerships with local entrepreneurs, according to a news report.
Mumbai: Reliance Group’s proposed entry into the diagnostic business threatens existing diagnostic players who fear the entry of India’s biggest corporate group with deep pockets will s... Read More
All Medical Devices To Be Regulated From December 1
The health ministry has proposed to notify all medical devices from December 1, expanding the span of regulation to ensure safety and efficacy of a variety of such products used for diagnosis.
EW DELHI: The health ministry has proposed to notify all medical devices from December ... Read More
Dop Lists Options To Rationalise Drug Trade Margins For Niti Aayog
In a meeting held earlier this month with Niti Aayog, DoP also suggested that trade margin on all formulations and dosages be capped at 100%.
NEW DELHI: In a bid to curb profiteering, the Department of Pharmaceuticals (DoP) has proposed a few options to rationalise the Read More
Jan Aushadhi Program: Challenges Vs Intent
The government’s Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) campaign should ideally be a runaway success.
By Dr. Vikram A Munshi
Founder at WhiteSpace Consulting & Capability Building
With the Indian healthcare industry seeing a robust growth trajectory, where the average per capita spending on healthcare in a year is just Rs 1,112, the government’s Read More
Mega Diabetes Drug To Be Cheaper Soon
With one of the relatively newer but important anti-diabetic drugs, Vildagliptin manufactured by Novartis, losing patent protection in December, dozens of companies are readying plans to launch the generic version to get a slice of the action in the growing Rs 13,000-crore diabetes therapy. The cost of therapy is expected to reduce by over 50%.
MUMBAI: There is some good news around the corner for the over 72 million diabetics in India, as cheaper versions of a blockbuster drug are expe... Read More
Price Of 1032 Medicines Capped By Govt: Mansukhlal Mandavia
He said Jan Aushadhi stores are opened with an aim of providing quality and affordable medicines to the poor.
The price of 1032 essential medicines have been capped by the government to help provide poor medicines at cheaper rates, the Rajya Sabha was informed Friday.
Min... Read More
Advent International Emerges Sole Bidder For Bharat Serums
Kotak PE and OrbiMed together hold 23% stake in BSV. The rest of the stake is with the Daftary family.
Mumbai: Private equity group Advent International has emerged as the sole contender for acquiring Mumbai-based biopharma company Bharat Serums and Vaccines (BSV) with a bid worth Rs 3,600 crore ($520 million) after rival contenders backed out of the two-year-long sale process,... Read More
Indian Pharma Industry Aspiring To Grow To $120-130 Billion By 2030: Ipa
he report, tiltled 'Indian Pharmaceutical Industry: The Way Forward - Vision 2030', is based on a research collaboration with McKinsey & Co and inputs from the IPA members and industry leaders, IPA said in a statement.
NEW DELHI: The Indian pharmaceutical industry is aspiring to touch USD 120-130 billion by 2030 from the current USD 38 billion, industry bod... Read More
Nagpur : Fbi, Czech Cops Trap City’s Pharma Exporter In Prague
Login